AI used to catch cancer in patients with cancelled appointments
AI software for early detection used to catch breast cancer in patients with cancelled appointments due to COVID-19
Chicago, IL, June 2020 — An artificial intelligence (AI)-based breast ultrasound software from Koios Medical, Inc. proven to significantly enhance the accuracy and consistency of lesion assessment for physicians across a wide range of experience levels, per a study recently published in the American Journal of Roentgenology, is now being used to diagnose breast cancer earlier for patients with appointments cancelled due to Covid-19.
Several community practices and major academic medical centers primarily in the Northeast and Midwest have adopted this first of its kind, FDA-cleared software recognizing that prior breast ultrasound images of patients whose appointments were postponed due to Covid-19 can be analyzed using the software uncovering previously missed cancers. High-risk patients can be immediately prioritized for biopsy and treatment if confirmed. Patients and providers benefit from this proactive approach taken by physicians during the Covid-19 induced slowdown that also postpones lower risk patient appointments. Up to 40% of patients scheduled for follow-up may safely defer follow-up an additional six to twelve months.